Tissue Distribution
Tissue Distribution - Related Videos
01:21
Drug Distribution: Tissue Binding
0 Views •
2023
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity. For...
11:39
Using Unfixed, Frozen Tissues to Study Natural Mucin Distribution
0 Views •
Cited by 39 •
2012
Unfixed frozen tissue samples embedded in Optimal Cutting Temperature medium (OCT) can be used to study natural distribution and glycosylation of secreted mucus. In this approach tissue processing is minimal and the natural presentation of glycolipids, mucins and glycan-epitopes is preserved. Tissue sections can be analyzed by immunohistochemistry using fluorescence or chromogenic detection.
01:30
Factors Affecting Drug Distribution: Tissue Permeability
0 Views •
2025
The drug distribution process within the human body is a complex interplay of various physicochemical properties inherent to the drugs. These properties, including molecular size, ionization degree, partition coefficient, and stereochemical nature, significantly impact how drugs permeate biological membranes to reach their target tissues. Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...
01:19
F Distribution
0 Views •
2023
The F distribution was named after Sir Ronald Fisher, an English statistician. The F statistic is a ratio (a fraction) with two sets of degrees of freedom; one for the numerator and one for the denominator. The F distribution is derived from the Student's t distribution. The values of the F distribution are squares of the corresponding values of the t distribution. One-Way ANOVA expands the t test for comparing more than two groups. The scope of that derivation is beyond the level of this...
01:25
Drug Distribution: Volume of Distribution
0 Views •
2023
The volume of distribution refers to the theoretical volume necessary to contain the entire amount of an administered drug at the same concentration observed in the blood plasma. The body's intracellular fluid compartment, which makes up two-thirds of the total body water, is contrasted with the extracellular fluid compartment—comprising plasma and interstitial fluid—that accounts for one-third. The volume of distribution can vary depending on the characteristics of the drug.
FAQs
Blood flow affects how quickly a substance or cell population reaches different organs, while tissue barriers determine whether it can enter those locations. Membrane permeability, transport proteins, and cellular uptake further control movement across barriers. Together, these factors can produce different local concentrations, helping explain why an intervention may act strongly in one tissue but weakly in another.
Binding to plasma or tissue components changes how much of a substance remains available for movement, uptake, or interaction within a tissue. Stronger association with these components can alter concentration patterns and persistence. Evaluating binding therefore helps researchers interpret whether measured tissue levels reflect active distribution, storage within tissue, or reduced availability for immediate effects.
Metabolism can transform a substance after it enters the body, while clearance removes the original substance or its products. These processes change concentrations at different time points and can shorten or extend tissue exposure. Tracking their influence helps distinguish brief delivery to a target site from sustained persistence and supports interpretation of time-dependent pharmacokinetic behavior.
Researchers compare where a treatment appears, how much accumulates, and how long it remains in organs or tissues. These observations add spatial information to pharmacokinetic analysis, which otherwise may not show local exposure clearly. The resulting profile can indicate whether concentrations reach intended sites and can help explain differences between systemic measurements and tissue-level effects.
Drug development uses tissue distribution assessments to examine whether a candidate reaches its intended site, accumulates in particular organs, or persists after administration. The findings can guide evaluation of targeted therapies and reveal exposure patterns relevant to safety. They are especially useful when beneficial activity depends on reaching a specific tissue while limiting contact with healthy tissues.
The distribution profile can show whether treatment-related material reaches the tissues expected to support its intended effect and whether it also appears in healthy tissues. It can reveal persistence or accumulation that may influence clinical behavior. By connecting location and duration of exposure with pharmacokinetic findings, researchers can better assess therapeutic targeting and potential safety concerns.